A detailed history of Snowden Capital Advisors LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 10,245 shares of ENZ stock, worth $7,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,245
Previous 12,045 14.94%
Holding current value
$7,581
Previous $13,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.04 - $1.18 $1,872 - $2,124
-1,800 Reduced 14.94%
10,245 $11,000
Q2 2024

Aug 14, 2024

SELL
$1.04 - $1.28 $8,736 - $10,752
-8,400 Reduced 41.09%
12,045 $13,000
Q4 2023

Feb 14, 2024

SELL
$1.21 - $1.44 $1,275 - $1,517
-1,054 Reduced 4.9%
20,445 $28,000
Q3 2023

Nov 14, 2023

SELL
$1.3 - $1.87 $1,560 - $2,244
-1,200 Reduced 5.29%
21,499 $30,000
Q2 2023

Aug 14, 2023

BUY
$1.84 - $2.66 $368 - $532
200 Added 0.89%
22,699 $41,000
Q1 2023

May 15, 2023

SELL
$1.0 - $2.51 $6,605 - $16,578
-6,605 Reduced 22.69%
22,499 $54,000
Q4 2022

Feb 13, 2023

SELL
$1.16 - $2.42 $3,016 - $6,292
-2,600 Reduced 8.2%
29,104 $41,000
Q3 2022

Nov 09, 2022

SELL
$2.1 - $2.73 $2,835 - $3,685
-1,350 Reduced 4.08%
31,704 $70,000
Q2 2022

Aug 12, 2022

SELL
$2.0 - $3.0 $6,000 - $9,000
-3,000 Reduced 8.32%
33,054 $68,000
Q1 2022

May 16, 2022

BUY
$2.9 - $3.47 $18,574 - $22,225
6,405 Added 21.6%
36,054 $104,000
Q4 2021

Feb 14, 2022

BUY
$3.17 - $4.09 $93,987 - $121,264
29,649 New
29,649 $95,000
Q3 2021

Feb 05, 2024

BUY
$3.01 - $3.77 $29,046 - $36,380
9,650 Added 44.89%
31,149 $110 Million
Q2 2021

Jan 08, 2024

SELL
$2.86 - $3.61 $1,144 - $1,444
-400 Reduced 1.26%
31,449 $99.7 Million
Q1 2021

Jan 08, 2024

BUY
$2.61 - $4.08 $2,218 - $3,468
850 Added 2.74%
31,849 $110 Million
Q4 2020

Jan 08, 2024

BUY
$1.82 - $2.61 $2,912 - $4,176
1,600 Added 5.44%
30,999 $78.1 Million
Q3 2020

Jan 08, 2024

BUY
$2.02 - $3.02 $3,232 - $4,832
1,600 Added 5.76%
29,399 $62 Million
Q2 2020

Jan 08, 2024

BUY
$2.12 - $3.22 $9,219 - $14,003
4,349 Added 18.55%
27,799 $62.3 Million
Q1 2020

Jan 08, 2024

SELL
$1.82 - $3.87 $3.53 Million - $7.51 Million
-1,941,550 Reduced 98.81%
23,450 $59.3 Million
Q4 2019

Jan 30, 2024

SELL
$2.57 - $3.68 $1,051 - $1,505
-409 Reduced 2.04%
19,650 $51.7 Million
Q4 2019

Jan 08, 2024

SELL
$2.57 - $3.68 $105,113 - $150,512
-40,900 Reduced 2.04%
1,965,000 $51.7 Million
Q3 2019

Jan 30, 2024

BUY
$3.01 - $4.0 $6,020 - $8,000
2,000 Added 11.07%
20,059 $72.2 Million
Q3 2019

Jan 08, 2024

BUY
$3.01 - $4.0 $6.04 Million - $8.02 Million
2,005,900 New
2,005,900 $72.2 Million
Q2 2019

Jan 30, 2024

SELL
$2.79 - $4.31 $9,597 - $14,826
-3,440 Reduced 16.0%
18,059 $60.9 Million
Q2 2019

Jan 08, 2024

SELL
$2.79 - $4.31 $45,781 - $70,722
-16,409 Closed
0 $0
Q1 2019

Jan 08, 2024

BUY
$2.54 - $4.02 $6,604 - $10,451
2,600 Added 18.83%
16,409 $44.8 Million
Q4 2018

Jan 08, 2024

BUY
$2.46 - $4.2 $9,102 - $15,540
3,700 Added 36.6%
13,809 $38.4 Million
Q3 2018

Jan 08, 2024

SELL
$3.81 - $5.53 $43,395 - $62,986
-11,390 Reduced 52.98%
10,109 $41.6 Million

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $36.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.